Harvard Bioscience
HBIO
HBIO
100 hedge funds and large institutions have $178M invested in Harvard Bioscience in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 6 closing their positions.
Holders
100
Holders Change
+35
Holders Change %
+53.85%
% of All Funds
1.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
27
Reduced
20
Closed
6
Calls
$164K
Puts
$1K
Net Calls
+$163K
Net Calls Change
+$157K
Top Buyers
| 1 |
1
BlackRock
New York
|
$14.4M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$3.44M |
| 3 |
3
Morgan Stanley
New York
|
$2.16M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.98M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$2.53M |
